Binimetinib

MEKTOVI

NADAC/unit N/A

No Shortage Tier 1: 17.9% PA Req: 99.4%

Covered Lives

Market Intelligence

2023-04-19 Class III Recall: Pfizer Inc.

Generic Manufacturers

ARRAY BIOPHARMA INC

Explore in the Ecosystem

rxsaver.aiCompare prices for Binimetinib drfinder.aiFind doctors who prescribe Binimetinib rxbenefits.aiEmployer cost impact analysis clinicalrx.aiClinical profile: Binimetinib

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.